| CBD | cannabidiol |
| THC | Δ9-tetrahydrocannabinol |
| ECS | endocannabinoid system |
| CB1 | cannabinoid receptor 1 |
| CB2 | cannabinoid receptor 2 |
| AEA | Anandamide |
| 2-AG | 2-arachidonoylglycerol |
| FAAH | fatty acid amide hydrolase |
| MAGL | monoacylglycerol lipase |
| TRPV | transient receptor potential vanilloid channel |
| 5-HT1A | serotonin 1A |
| PPAR | peroxisome proliferator-activated receptor |
| GPR | G protein-coupled receptor |
| AHR | airway hyperreactivity |
| Th2 | T helper 2 |
| ILC2 | type 2 innate lymphoid cells |
| IgE | immunoglobulin E |
| TSLP | thymic stromal lymphopoietin |
| TNF-α | tumor necrosis factor-α |
| PEF | peak expiratory flow |
| FEV1 | forced expiratory volume in 1 s |
| GCS | glucocorticosteroids |
| BALF | bronchoalveolar-lavage fluid |
| IL | interleukin |
| Tregs | regulatory T cells |
| TGF-β | transforming growth factor β |
| COPD | chronic obstructive pulmonary disease |
| EVALI | e-cigarette- and vaping-associated lung illness |